Found: 7
Select item for more details and to access through your institution.
Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 3, p. 585, doi. 10.1007/s10549-018-5022-5
- By:
- Publication type:
- Article
The Non-Coding RNA Landscape of Plasma Cell Dyscrasias.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 320, doi. 10.3390/cancers12020320
- By:
- Publication type:
- Article
Emicizumab in children: bleeding episodes and outcome before and after transition to Emicizumab.
- Published in:
- BMC Pediatrics, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12887-022-03546-1
- By:
- Publication type:
- Article
Emicizumab in children: bleeding episodes and outcome before and after transition to Emicizumab.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Pathophysiologic Role of JunB in Multiple Myeloma Pathogenesis: Focus on Angiogenesis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S77, doi. 10.1016/j.clml.2016.07.107
- By:
- Publication type:
- Article
Pre-Osteoblasts Stimulate Migration of Breast Cancer Cells via the HGF/MET Pathway.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0150507
- By:
- Publication type:
- Article
A Novel GATA1 Variant in the C-Terminal Zinc Finger Compared with the Platelet Phenotype of Patients with A Likely Pathogenic Variant in the N-Terminal Zinc Finger.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 20, p. 3223, doi. 10.3390/cells11203223
- By:
- Publication type:
- Article